The purported proliferation of substandard paracetamol in Nigeria’s pharmaceutical industry prompted a response from the National Agency for Food and Drug Administration, or NAFDAC.
Sayo Akintola, the media consultant for NAFDAC, made it clear in a statement on Monday that there isn’t any proof that subpar paracetamol is being distributed in the nation.
The public was reassured by the agency of its vigilante efforts to protect the health of the country.
“We have received a copy of the publication of the research findings on the subject, and we wish to state categorically that the report is misleading and the science is questionable.
“We do a yearly post-marketing survey of medicines to ensure that the quality and safety are maintained. Where there is a deviation from this, i.e., when we find any regulated product to be substandard or falsified, NAFDAC regularly issues public alerts or recalls.
“NAFDAC wishes to reassure the public that the agency is very vigilant in safeguarding the Nation’s health”, he stated.